A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) — Stella
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
(119 sites) United States
Los Angeles Cancer Network, Los Angeles, California Valkyrie Clinical Trials, Los Angeles, California Pih Health Hematology Medical Oncology, Whittier, California Orchard Healthcare Research Inc., Skokie, Illinois M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota NYU Langone Health, New York, New York Icahn School of Medicine At Mount Sinai Prime, New York, New York Clinical Research Alliance, Westbury, New York Tn Gynecologic Oncology Group, Llc, Chattanooga, Tennessee The West Clinic, Germantown, Tennessee SCRI Oncology Partners, Nashville, Tennessee Texas Oncology - West Texas, Amarillo, Texas Texas Oncology, P.A., Dallas, Texas Texas Oncology Gulf Coast, Pearland, Texas University of Utah Hospitals & Clinics, Salt Lake City, Utah Virginia Cancer Specialists, Fairfax, Virginia Wenatchee Hospitals and Clinics, Wenatchee, Washington Argentina
Hospital Aleman, Buenos Aires Hospital Sirio Libanes, Caba Centro Médico Austral, Ciudad Autonoma Buenos Aires Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata Australia
Genesiscare North Shore Oncology, St Leonards, New South Wales Blacktown Hospital, Blacktown St Vincent'S Hospital Sydney, Mount Kuring-Gai St John of God Subiaco Hospital, Subiaco Princess Alexandra Hospital, Woolloongabba Belgium
Cliniques Universitaires Saint-Luc, Brussels Grand Hospital de Charleroi, Charleroi Universitair Ziekenhuis Gent, Ghent Brazil
Hospital de Câncer de Barretos - Fundação Pio XII, Barretos Cepon - Centro de Pesquisas Oncolă"Gicas de Santa Catarina, Florianópolis Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho, Jaú Hospital de Clínicas de Porto Alegre, Porto Alegre Hospital São Lucas Da Pucrs, Porto Alegre Chile
Ic La Serena Research, La Serena Centro Del Cancer UC, Santiago Clinica Redsalud Vitacura, Santiago James Lind Centro de Investigacion Del Cancer, Temuco France
Centre Léon Bérard, Lyon, Rhone Chu Besançon - Hôpital Jean Minjoz, Besançon Hopital Saint Andre, Bordeaux Institut Bergonié, Bordeaux Centre Georges François Leclerc, Dijon Institut Régional Du Cancer de Montpellier, Montpellier Institut Curie - Site de Paris, Paris CRLCC Eugene Marquis, Rennes Ico - Site René Gauducheau, Saint-Herblain Institut Claudius Regaud, Toulouse Institut Gustave Roussy, Villejuif Germany
Charită - Campus Charită Mitte, Berlin Vivantes Klinikum Neukoelln, Berlin Staedtisches Klinikum Dresden Standort Dresden-Friedrichstadt, Dresden Universitaetsklinikum Heidelberg, Heidelberg Slk-Kliniken Heilbronn Gmbh, Heilbronn Universitäres Krebszentrum Leipzig UCCL, UKL AöR, Leipzig Univ der Johannes GutenbergU, Mainz Universitätsklinikum Münster, Medizinische Klinik A, Münster Ireland
Cork University Hospital, Cork Mater Misericordiae University Hospital, Dublin Tallaght University Hospital, Dublin St Vincent'S University Hospital, Dublin University Hospital Galway, Galway Italy
Fondazione Del Piemonte Per L'Oncologia Irccs Candiolo, Candiolo Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milan Istituto Nazionale Tumori Fondazione G. Pascale, Naples Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome Istituto Clinico Humanitas, Rozzano Japan
National Cancer Center Hospital, Chūōku National Cancer Center Hospital East, Kashiwa The Cancer Institute Hospital of Jfcr, Kōtoku National Hospital Organization Shikoku Cancer Center, Matsuyama Shizuoka Cancer Center, Nagaizumi-cho Aichi Cancer Center Hospital, Nagoya Kindai University Hospital, Ōsaka-sayama Saitama Cancer Center, Saitama Mexico
Medical Care & Research Sa de Cv, Mérida Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida Cryptex Investigacion Clinica S.A. de C.V., México Netherlands
Amsterdam Umc, Locatie Vumc, Amsterdam Universitair Medisch Centrum Groningen, Groningen Radboudumc Nijmegen, Nijmegen Erasmus Medisch Centrum, Rotterdam Erasmus Medisch Centrum, Rotterdam Poland
SPZOZ Szpital Uniwer w Krakowie, Krakow Instytut MSF Sp. z o.o., Lodz MRUK-MED i Spółka z ograniczoną odpowiedzialnością, Rzeszów Mazowiecki Szpital Wojewodzki W Siedlcach Sp Z O O, Siedlce Aidport Sp Z O.O., Skorzewo Portugal
Instituto Portuguă S de Oncologia de Lisboa Francisco Gentil, Epe, Lisbon Fundação Champalimaud, Lisbon Centro Hospitalar Universitário de Lisboa Norte, Lisbon Centro Hospitalar Universitario de Santo Antonio, Porto Inst Portude Onco do Porto, Porto Spain
Hospital Clinic de Barcelona, Barcelona ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona Hospital Universitari Vall D'Hebron, Barcelona Hospital General Universitario Gregorio Marañon, Madrid Hospital Clínico San Carlos, Madrid Hospital Universitario 12 de Octubre, Madrid Hospital Universitario La Paz, Madrid Hospital Universitario Virgen Macarena, Seville Taiwan
China Medical University Hospital, Taichung National Cheng Kung University Hospitalx, Tainan National Taiwan University Hospital, Taipei Taipei Veterans General Hospital, Taipei Koo Foundation Sun Yat-Sen cancer center, Taipei Tri-Service General Hospital, Taipei Turkey (Türkiye)
Gulhane Training and Research Hospital, Ankara Gazi University Medical Faculty, Ankara Ankara University Cebeci Hospital, Ankara Ankara City Hospital, Ankara Medipol Mega University Hospital, Istanbul Izmir Medicalpark Hospital, Izmir
Key details Collaborators
Merck Sharp & Dohme LLC
Enrollment target
~520 participants
Primary completion
July 2028
Last updated February 2026